Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Diagnostic/prognostic biomarkers Drug targets Novel mutations Validation of in vitro & in vivo HCC models Relevance ?634 Consistently altered metabolic genes in human HCC SUMMARYWe have identified metabolic targets that are consistently altered in human hepatocellular carcinoma, and are of potential clinical significance.This study exposes profound genomic dysregulation that could shed new light on how metabolism influences hepatocellular carcinogenesis. BACKGROUND & AIMS:Cancer cells rely on metabolic alterations to enhance proliferation and survival.Metabolic gene alterations that repeatedly occur in liver cancer are largely unknown.We aimed to identify metabolic genes that are consistently deregulated, and are of potential clinical significance in human hepatocellular carcinoma (HCC). METHODS:We studied the expression of 2,761 metabolic genes in 8 microarray datasets comprising 521 human HCC tissues.Genes exclusively up-regulated or down-regulated in 6 or more datasets were defined as consistently deregulated.The consistent genes that correlated with tumor progression markers (ECM2 and MMP9) (Pearson correlation P < .05)were used for Kaplan-Meier overall survival analysis in a patient cohort.We further compared proteomic expression of metabolic genes in 19 tumors vs adjacent normal liver tissues.RESULTS: We identified 634 consistent metabolic genes, w60% of which are not yet described in HCC.The downregulated genes (n ¼ 350) are mostly involved in physiologic hepatocyte metabolic functions (eg, xenobiotic, fatty acid, and amino acid metabolism).In contrast, among consistently up-regulated metabolic genes (n ¼ 284) are those involved in glycolysis, pentose phosphate pathway, nucleotide biosynthesis, tricarboxylic acid cycle, oxidative phosphorylation, proton transport, membrane lipid, and glycan metabolism.Several metabolic genes (n ¼ 434) correlated with progression markers, and of these, 201 predicted overall survival outcome in the patient cohort analyzed.Over 90% of the metabolic targets significantly altered at the protein level were similarly up-or down-regulated as in genomic profile. CONCLUSIONS:We provide the first exposition of the consistently altered metabolic genes in HCC and show that these genes are potentially relevant targets for onward studies in preclinical and clinical contexts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NCBI GEO: archive for functional genomics data sets—update
Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1193 · Cited by 10,418 · cited 1×
“Methods Collection of Liver Cancer Microarray Datasets, Processing and Identification of Consistently Altered Metabolic Genes Eight liver cancer microarray datasets that have accompanying scientific publications (Table 1) were assembled via online databases, namely ArrayExpress(32) and the Gene Expression Omnibus (GEO…”
MethodThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“In line with the rapidly evolving insights on tumor metabolism, a recent review has grouped the emerging alterations into 6 hallmarks, among which are deregulated uptake of glucose and amino acids, increased demand for nitrogen, and altered gene regulation caused by buildup of metabolites such as acetyl coenzyme A and…”
BackgroundMatrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120
Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678 · cited 1×
“In line with our finding in human HCC, the down-regulation of FA genes has been reported in mice exposed to chronic choline-deficient highfat diet in which NASH transited to HCC.(46) Thus, impaired FA metabolism may represent an early event in HCC development that is consistent even across species, but yet unappreciat…”
ResultSchell, J. C., Olson, K. A., Jiang, L., Hawkins, A. J., Van Vranken, J. G., Xie, J., Egnatchik, R. A., Earl, E. G., DeBerardinis, R. J., & Rutter, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.026 · Cited by 363 · cited 2×
“MPC1 has been reported to be downregulated in NASH patients,(47) and has been identified as a repressor of Warburg effect in cancer.(49) MPC1 was also previously shown to be consistently down-regulated in HCC and several other cancers, and is induced upon glutamine”
BackgroundTrivedi, P. J., Lammers, W. J., van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308351 · Cited by 178 · cited 1×
“One notable liver function enzyme, aspartate transaminase, has also recently been shown to predict future risk of HCC development from primary biliary cirrhosis.(23) Therefore, identification of the consistently deregulated metabolic genes in HCC will accelerate future mechanistic studies aimed at exploiting specific…”
Background
Cited by
Scheau, C., Badarau, I. A., Costache, R., Caruntu, C., Mihai, G. L., Didilescu, A. C., Constantin, C., & Neagu, M. (2019) · Analytical Cellular Pathology · doi:10.1155/2019/9423907 · Cited by 367
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“Moreover, numerous studies indicate enhanced amino acid metabolism in liver tumors compared to non-tumor tissues [1, 31, 37, 60, 61].”
BackgroundTuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1029-y · Cited by 84
Dai, W., Shen, J., Yan, J., Bott, A. J., Maimouni, S., Daguplo, H. Q., Wang, Y., Khayati, K., Guo, J. Y., Zhang, L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161408 · Cited by 70
Kowalik, M. A., Puliga, E., Cabras, L., Sulas, P., Petrelli, A., Perra, A., Ledda-Columbano, G. M., Morandi, A., Merlin, S., Orrù, C., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.018 · Cited by 62
Metadata
- Authors
- Nwosu, Z. C., Megger, D. A., Hammad, S., Sitek, B., Roessler, S., Ebert, M. P., Meyer, C., & Dooley, S.
- Venue
- Cellular and Molecular Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 4
- Issue
- 2
- Pages
- 303-323.e1
- ISSN
- 2352-345X (ISSN-L)
- OpenAlex
- W2621219284
- Cited by
- 151
- References
- 12
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.